PHIO PHARMACEUTICALS CORP (PHIO)

US71880W5013 - Common Stock

2.23  +0.47 (+26.7%)

After market: 2.18 -0.05 (-2.24%)

PHIO PHARMACEUTICALS CORP

NASDAQ:PHIO (12/23/2024, 10:32:47 PM)

After market: 2.18 -0.05 (-2.24%)

2.23

+0.47 (+26.7%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%84.99%
Sales Q2Q%N/A
CRS4.21
6 Month-64.19%
Overview
Earnings (Last)11-07 2024-11-07/dmh
Earnings (Next)N/A N/A
Ins Owners6.03%
Inst Owners2.56%
Market Cap2.36M
Shares1.06M
PEN/A
Fwd PE0.06
Dividend YieldN/A
Analysts82.86
Short Float %4.81%
Short Ratio0.76
IPO05-10 2012-05-10
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PHIO Daily chart

Company Profile

Phio Pharmaceuticals Corp is a US-based company operating in Biotechnology industry. The company is headquartered in Marlborough, Massachusetts and currently employs 8 full-time employees. The company went IPO on 2012-05-10. Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The firm's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The company is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. The firm's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.

Company Info

PHIO PHARMACEUTICALS CORP

11 Apex Drive, Suite 300A, Pmb 2006

Marlborough MASSACHUSETTS 01752

P: 15087673861

CEO: Gerrit Dispersyn

Employees: 9

Website: https://phiopharma.com/

PHIO News

ChartMill News Image9 hours ago - ChartmillTop movers in Monday's after hours session

Monday's after hours session: top gainers and losers

News Image13 hours ago - NewsfilePhio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...

ChartMill News Image13 hours ago - ChartmillThese stocks have an unusual volume in today's session

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

ChartMill News Image15 hours ago - ChartmillWhich stocks are gapping on Monday?

Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

ChartMill News Image17 hours ago - ChartmillDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image4 days ago - NewsfilePhio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 19, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...

PHIO Twits

Here you can normally see the latest stock twits on PHIO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example